Studies conducted at our Institute showed that p53 positivity combined with Bcl-2 negativity and elevated Ki-67 score correlated with advanced tumor stage, poorly differentiated tumors and increased probability of relapse. This evidence concerns the gene BCL2 and neoplasm.